Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Understand what expenses to consider in retirement for effective budgeting. Prepare for a financially sound future!
18,123 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A data center spending surge across AI giants is reshaping markets. This article explains how a single company could ...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
With $5,000 to invest, you don’t need a splashy portfolio. Two proven tech leaders can offer growth and staying power...
The first watch restaurant stock has cooled off after a strong earnings showing, but the story isn’t just about numbe...
Authorities say 72 tigers died thai zoos in Chiang Mai from canine distemper, not bird flu, easing human health fears...
A sharp drop in Oddity Tech shares sparked questions about the health of a high-growth tech play. Even with solid qua...
Dogecoin pulled back after a brisk rally, erasing part of yesterday's gains. This guide explains what caused the drop...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
As blockchains shed some public-by-default assumptions, ethereum both pivoting privacy raises questions for investors...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Investors awakened to a rough start for cruise stocks as Norwegian Cruise Line Holdings shares slid. This piece break...